Dupont Capital Management Corp Lannett CO Inc Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$6.36 - $10.05 $216,799 - $342,584	-34,088 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$8.49 - $12.81 $201,145 - $303,494	-23,692 Reduced 41.0%	34,088 $301,000
Q3 2019 Oct 28, 2019	SELL	$5.58 - $14.47 $34,568 - $89,641	-6,195 Reduced 9.68%	57,780 $647,000
Q2 2019 Jul 30, 2019	BUY	$5.22 - $9.08 $134,237 - $233,501	25,716 Added 67.22%	63,975 $388,000
Q1 2019 Apr 30, 2019	BUY	$5.35 - $9.82 $204,685 - $375,703	38,259 New	38,259 $301,000
Q4 2018 Feb 01, 2019	SELL	$3.43 - $6.19 $221,800 - $400,276	-64,665 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$13.3 - $17.45 $102,822 - $134,905	7,731 Added 13.58%	64,665 $879,000
Q4 2017 Jan 31, 2018	BUY	$19.9 - $29.25 $1.13 Million - $1.67 Million	56,934	56,934 $1.32 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.